CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Open-market sale Director sold 1,700 shares at $109.83 ($186,716)
- 4 Open-market sale Director sold 6,467 shares at an average $107.17 ($693,039)
- 4 Open-market sale Director sold 3,533 shares at $107.10 ($378,378)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 16,653 shares (grant or award)
- 4 Open-market sale Director sold 100 shares at $113.70 ($11,370)
- 4 Open-market sale Director sold 100 shares at $111.03 ($11,103)
- 4 Shares withheld for taxes SVP Clinical Controls gave up 309 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - General Counsel gave up 277 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - Novus Biologicals gave up 533 shares (to pay taxes)
- 4 Open-market sale Director sold 100 shares at $112.15 ($11,215)
- 4 Open-market sale Director sold 100 shares at $102.53 ($10,253)
- 4 Open-market sale Director sold 5,000 shares at $101.91 ($509,550)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Open-market sale Director sold 500 shares at $100.24 ($50,120)
Page 20 of 35 · 695 filings